Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal ...

Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer ...

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive ...

Dr. Raajit K. Rampal and Dr. Joshua K. Sabari walk through updates for patients in the treatment of blood cancers, including polycythemia vera.

Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.

I can still clearly remember people’s reactions after I finished chemo for the first time in 2014, a few months after my ...

Dr. Michael Serzan explains the importance of clinical trial enrollment for patients with kidney cancer and highlighted findings from the STELLA-002 trial.

FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a ...

Dr. Jared Weiss explained that radiation for lung cancer may ease symptoms or aim to cure, with newer targeted forms ...